Combination Chemo Regimens Flashcards

1
Q

ABVD

A

Hodgkins Lymphoma

Doxorubicin 25 mg/m2
Bleomycin 10 mg/m2
Vinblastine 6mg/m2
Dacarbazine (DTIC) 375 mg/m2

Days 1 and 15 every 28 day cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tafasitamab-cxix + Lenalidomide

A

“Tafa-Len”
Monjuvi®

relapsed or refractory diffuse large B-cell lymphoma

Antibody-Drug Conjugate-CD19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Loncastuximab tesirine

A

“Lonca-T”
ZYNLONTA®

relapsed or refractory diffuse large B-cell lymphoma

antibody-drug conjugate CD19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

FCR

A

Chronic Lymphocytic Leukemia (CLL)

Fludarabine: 25 mg/m2 IV days 1-3
Cyclophosphamide: 250 mg/m2 IV days 1-3
Rituximab*: 375 mg/m2 IV day 1

Cycle: 28 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

R-CHOP

A

Non-Hodgkin Lymphomas (NHLs)

Cyclophosphamide 750 mg/m2 IV on day 1
Doxorubicin 50 mg/m2 IV on day 1
Vincristine 1.4 mg/m2 (maximum dose of 2mg per cycle) IV on day 1
Prednisone 100 mg PO QD on days 1-5
Rituximab 375 mg/m2 IV on day 1

Cycle: 21 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

FLAG-IDA

A

AML Consolidation

-1 to 6 (7 days) G-CSF 5mcg/kg

1, 2,3,4,5, Fludarabine 30mg/m2

1,2,3,4,5, Cytarabine 2 g/m2

3, 4, and 5 Idarubicin 8mg/m2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BEP

A

Testicular Germ Cell Tumors

Bleomycin 30 mg/m2
days 1, 8, and 15

Etoposide 100 mg/m2
Days 1-5

Cisplatin (Platinol) 20 mg/m2
Days 1-5

21 day cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

R-ICE

A

Lymphomas

Rituximab 375 mg/m2 (1,7,14)
Ifosfamide 2 g/m2 + Mesna (3,4,5)
Carboplatin AUC 5 (3,4,5)
Etoposide 75 mg/m2 (3,4,5)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BEACOPP

A

Bleomycin 10 mg/m2
Etoposide 100 mg/m2
Doxorubicin 25 mg/m2
Cyclophosphamide 650 mg/m2
Vincristine 1.4 mg/m2
Procarbazine 100 mg/m2
Prednisone 40 mg/m2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Teclistamab

A

TECVAYLI™ Janssen

BISPECIFIC B-cell maturation antigen (BCMA)-directed CD3 T-cell engager

R/R Multiple Myeloma after 4 prior lines of therapy

risk of CRS and neurologic toxicity, including ICANS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hyper CVAD

A

CycloPHOSphamide 300 mg/m2 IV over 3 hours every 12 hours for 6 doses on Days 1 – 3

DOXOrubicin 50 mg/m2 IV push or IV continuous infusion over 24 hours on Day 4

VinCRIStine 2 mg IV over 5 – 10 minutes on Days 4 and 11

DexAMETHasone 40 mg IV or PO daily on Days 1 – 4 and 11 – 14

21-day cycle for 4 cycles alternating with high-dose methotrexate/cytarabine:
Methotrexate 12 mg intrathecal Day 2
Cytarabine 100 mg intrathecal Day 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly